Australia CBD Products Market Size, Share, Trends, Growth, and Forecast form 2025 to 2033

The latest report by IMARC Group, “Australia CBD Products Market Size, Share, Trends and Forecast by Source, Distribution Channel, Application, and Region, 2025-2033,” provides an in-depth analysis of the Australia CBD Products Market. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry. The Australia CBD products market size reached USD 0.22 Billion in 2024 and is projected to grow to USD 0.50 Billion by 2033, exhibiting a CAGR of 9.61%during the forecast period.

Australia CBD Products Market Overview:

The Australian CBD products market is experiencing strong growth as more customers use cannabidiol for wellness, therapeutic, and skincare purposes. Companies are launching innovative products, including gummies, capsules, and topical creams. Government regulations are evolving to allow easier access to low-dose CBD products over the counter. This change is enabling pharmaceutical and cosmetic companies to expand their portfolios, while awareness campaigns and clinical research are helping normalize CBD usage across demographics.

Request For Sample Report: https://www.imarcgroup.com/australia-cbd-products-market/requestsample

Australia CBD Products Market Trends and Drivers:

CBD product developers are incorporating nanotechnology and encapsulation methods to enhance bioavailability and effectiveness. Retail pharmacies and online platforms are increasing their CBD offerings amid high consumer demand. The food and beverage sector is progressively introducing CBD-infused drinks and snacks. Companies are also forming partnerships with healthcare providers and wellness centers to promote medical-grade products. Consumer preference is shifting toward naturally sourced, THC-free formulas for general health maintenance.

The growing demand for natural and alternative therapeutic solutions is driving CBD product adoption across Australia. Common issues being addressed with CBD include chronic pain management, anxiety, and sleep disorders, which support market growth. Regulatory changes allowing over-the-counter access to specific CBD dosages are lowering barriers to entry. Increased investment in clinical trials, marketing campaigns, and health-conscious consumer behavior are also contributing to rapid market expansion.

Market Challenges and Opportunities:

The Australian CBD products market is grappling with significant regulatory uncertainty—low-dose CBD (up to 150 mg/day) has been down-scheduled to Schedule 3, which potentially enables over-the-counter pharmacy sales, yet to date no product has received TGA approval for OTC access, keeping access strictly prescription-based and limiting mainstream adoption. Maintaining high standards for product quality and safety is another major challenge; inconsistent potency, poor labeling, and variable THC levels have eroded consumer confidence. Fragmentation within the market due to numerous small-scale providers further complicates brand reputation, consistency, and regulatory compliance.

On the opportunity side, rising consumer interest in natural wellness, plant-based remedies, and preventive health is fueling demand across segments—from oils and capsules to topicals and beverages. Ongoing research into clinically validated CBD formulations is unlocking new use cases for managing anxiety, sleep disorders, inflammation, and pain, offering product differentiation potential. Additionally, the evolving regulatory environment—including possible future approval of OTC CBD products and clearer industry pathways—presents a significant growth corridor for brands that can invest in rigorous testing, certification, and transparent communication. With the market expected to grow significantly, Australia is becoming a potential hub for medically compliant and export-ready CBD innovation.

Australia CBD Products Key Growth Drivers:

• Regulatory reforms allowing OTC access to low-dose CBD
• Rising public awareness about therapeutic benefits of CBD
• Expansion of e-commerce and retail pharmacy distribution
• Increased use in functional foods, cosmetics, and health supplements
• Investment in R&D and clinical trials supporting product credibility

Browse Full Report with TOC & List of Figures: https://www.imarcgroup.com/australia-cbd-products-market

Australia CBD Products Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional level for 2025-2033. Our report has categorized the market based on source, distribution channel, and application.

Source Insights:

• Hemp
• Marijuana

Distribution Channel Insights:

• B2B
• B2C

Application Insights:

• Pharmaceutical
• Wellness

Regional Insights:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Queensland
• Northern Territory & Southern Australia
• Western Australia

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

• AusCann Group Holdings Ltd.
  • Botanix Pharmaceuticals Limited
  • Cann Group Limited
  • Cannatrek Ltd.
  • Creso Pharma
  • ECS Botanics Holdings Ltd.
  • Elixinol Wellness Limited
  • Little Green Pharma
  • Medlab Clinical Limited
  • THC Global Group Limited

Australia CBD Products Market News:

May 2025: Creso Pharma partners with wellness clinics across Australia to roll out new topical CBD pain relief products.

March 2025: Australian government updates CBD scheduling laws to allow broader access to over-the-counter low-dose CBD products.

Note: If you require specific information not currently within the scope of the report, we can provide it as part of the customization.

Ask an analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=33027&flag=C

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel. No.: (D) +91 120 433 0800
Americas: +1 631 791 1145